一个前性队列研究超急性皮下免疫疗法在灰尘引发的过敏性鼻炎
Yishan Xiong1, Wenqi Luo1, Hao Peng1
1Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, PR China.
超急性皮下免疫疗法 (UR-SCIT) 对过敏性鼻炎的疗效和安全性与集群SCIT相提并论. 这种快速免疫疗法对于寻求有效因果治疗的患者来说是一个可行的新选择.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 临床医学 临床医学
背景情况:
- 过敏性鼻炎 (AR) 是一种常见的疾病,具有重大的全球影响.
- 过敏原免疫疗法 (AIT) 是对AR的主要因果治疗方法.
- 像集群皮下免疫疗法 (Cluster SCIT) 这样的加速AIT计划减少了治疗时间,但超急性皮下免疫疗法 (UR-SCIT) 需要直接比较.
研究的目的:
- 为了前性地比较UR-SCIT与集群SCIT在家用粉尘引发的AR的疗效和安全性.
- 评估这两种快速AIT协议的临床和免疫结果.
主要方法:
- 一项为期12个月的前性研究,涉及57名AR患者,比较UR-SCIT和集群SCIT.
- 通过视觉模拟量表 (VAS),犀牛结膜炎生活质量调查问卷 (RQLQ) 和综合症状和药物评分 (CSMS) 评估有效性.
- 免疫学标志物 (SPT,NAC,FeNO,FnNO,血液中氨基酸,血清细胞因子,IgE,IgG4) 和不良反应被监测.
主要成果:
- 无论是UR-SCIT还是集群SCIT都显著改善了AR症状和生活质量,减少了皮肤刺伤测试等级.
- 免疫学变化包括降低乙氨基和促炎细胞因子 (IL-4,IL-5,IL-13,IL-33),增加IL-10.
- 在UR-SCIT和集群SCIT之间没有观察到有效性或安全性的显著差异,没有报告严重不良事件.
结论:
- 在治疗过敏性鼻炎方面,UR-SCIT的治疗效果与集群SCIT相似.
- 这两种快速AIT方法都提供了显著的症状控制和有利的免疫调节.
- 在临床实践中,UR-SCIT为AIT提供了安全有效的替代方案.
更多相关视频
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Allergic Reactions: Anaphylaxis
